EGFR and lung adenocarcinoma: In clinical practice, platinum in combination with pemetrexed is the treatment of choice for patients with EGFR wild-type lung adenocarcinoma, whereas platinum combined with gemcitabine is the drug of choice for patients with lung SCC.